Orchid Chemicals gets USFDA nod for cefpodoxime proxetil

New Delhi, Nov 16 (UNI) Orchid Chemicals&Pharmaceuticals Ltd today said it has received the US Food and Drug Administration (USFDA) approval for its cefpodoxime proxetil antibiotic tablets in multiple strengths.

The drug is a third generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases.

With limited generic competition in this product, the company hopes to garner a sizeable market share and revenues in the US market, it said in a statement.

The product is available in two dosage strengths, 100 mg and 200 mg.

UNI